News & Perspective

Aug 10, 2007

Aug 10, 2007

Researchers create H5N1 mutations to pave way for new vaccines and treatments

(CIDRAP News) – Global health officials have long feared genetic changes that would make the H5N1 avian influenza virus more easily transmissible among humans, but a new report from researchers at the National Institute of Allergy and Infectious Diseases (NIAID) predicts some of the crucial mutations, which could open the door to preemptive vaccines and treatments.